Pharmaceutical Product Manufacturing in Australia - Industry Market Research Report
Description
Pharmaceutical Product Manufacturing in Australia
Favourable demand factors have driven revenue growth in recent years, including an ageing population and a greater incidence of chronic disease. Increased local and global demand for consumer healthcare products has also benefited several participants. However, ongoing challenges including a changing regulatory and risk environment and reform-driven pricing pressures have constrained the industry's growth. Ongoing PBS reforms have heavily influenced manufacturers over the period, as mandatory price disclosures and a greater reliance on generic drugs have continued to reduce prices and added to downward profitability pressures.
The industry comprises companies that manufacture medicinal and pharmaceutical products for human use from both synthetic (chemical) and natural sources. Other products include chemical or diagnostic testing agents, blood serums and biotech products. Industry activities include manufacturing active pharmaceutical ingredients and synthesising chemical ingredients, late-stage packaging and fill-finish activities.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Favourable demand factors have driven revenue growth in recent years, including an ageing population and a greater incidence of chronic disease. Increased local and global demand for consumer healthcare products has also benefited several participants. However, ongoing challenges including a changing regulatory and risk environment and reform-driven pricing pressures have constrained the industry's growth. Ongoing PBS reforms have heavily influenced manufacturers over the period, as mandatory price disclosures and a greater reliance on generic drugs have continued to reduce prices and added to downward profitability pressures.
The industry comprises companies that manufacture medicinal and pharmaceutical products for human use from both synthetic (chemical) and natural sources. Other products include chemical or diagnostic testing agents, blood serums and biotech products. Industry activities include manufacturing active pharmaceutical ingredients and synthesising chemical ingredients, late-stage packaging and fill-finish activities.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
47 Pages
- TABLE OF CONTENTS
ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources
INDUSTRY AT A GLANCE
INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
PRODUCTS & MARKETS
Supply Chain
Products & Services
Demand Determinants
Major Markets
International Trade
Business Locations
COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization
MAJOR COMPANIES
OPERATING CONDITIONS
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance
KEY STATISTICS
Industry Data
Annual Change
Key Ratios
JARGON & GLOSSARY
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
